EDAP TMS reported EUR15.01M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
AngioDynamics USD 41.64M 14.26M Sep/2025
Boston Scientific USD 539M 914M Jun/2026
EDAP TMS EUR 15.01M 14.82M Mar/2026
Henry Schein USD 157M 19M Jun/2026
Medtronic USD 1.69B 258M Jun/2026
Plus Therapeutics USD 2.37M 656K Jun/2026
Veracyte USD 299.52M 36.38M Jun/2026